Quantum (NASDAQ:QMCO – Get Free Report) and Ainos (NASDAQ:AIMD – Get Free Report) are both small-cap technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, risk, earnings and analyst recommendations.
Risk & Volatility
Quantum has a beta of 3.23, meaning that its stock price is 223% more volatile than the S&P 500. Comparatively, Ainos has a beta of 2.65, meaning that its stock price is 165% more volatile than the S&P 500.
Insider and Institutional Ownership
63.7% of Quantum shares are owned by institutional investors. 41.0% of Quantum shares are owned by insiders. Comparatively, 9.8% of Ainos shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Valuation and Earnings
This table compares Quantum and Ainos”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Quantum | $279.58 million | 2.30 | -$101.05 million | ($13.24) | -1.23 |
| Ainos | $120,000.00 | 28.86 | -$14.77 million | ($2.52) | -0.19 |
Ainos has lower revenue, but higher earnings than Quantum. Quantum is trading at a lower price-to-earnings ratio than Ainos, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Quantum and Ainos’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Quantum | -73.54% | -3.52% | 2.90% |
| Ainos | N/A | -217.50% | -67.87% |
Analyst Recommendations
This is a summary of current ratings for Quantum and Ainos, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Quantum | 1 | 0 | 5 | 0 | 2.67 |
| Ainos | 1 | 0 | 0 | 0 | 1.00 |
Quantum presently has a consensus target price of $28.33, indicating a potential upside of 73.82%. Given Quantum’s stronger consensus rating and higher possible upside, equities analysts plainly believe Quantum is more favorable than Ainos.
Summary
Quantum beats Ainos on 9 of the 13 factors compared between the two stocks.
About Quantum
Quantum Corporation provides data storage and management solutions for organizations that create and retain large volumes of unstructured data, including video, images and other digital content. Its customers include businesses and institutions in areas such as media and entertainment, government, life sciences and industrial markets. The company’s offerings include StorNext shared-storage and data-management software, Scalar tape libraries for backup and archiving, and ActiveScale object storage.
About Ainos
Ainos, Inc. is a healthcare technology company focused on developing artificial intelligence-enabled point-of-care testing, telehealth solutions and low-dose interferon therapeutics. Its technologies are intended to support faster, more accessible testing and treatment in clinical and other healthcare settings. The company’s development portfolio has included AI Nose, a platform designed to analyze volatile organic compounds for potential disease screening, as well as Ainos Flora, a point-of-care molecular testing product being developed for the detection of common vaginal infections.
Receive News & Ratings for Quantum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum and related companies with MarketBeat.com's FREE daily email newsletter.
